Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07254975

An Observational Prospective Study of Anesthetic Sensitivity Assessed by Alpha Band Power and Its Association With Emergence Time From Sevoflurane General Anesthesia in Young Adults.

The goal of this observational study is to determine the relationship between brain activity patterns and recovery time in adult patients (ages 35-50, ASA I-II) undergoing elective general anesthesia.

The main question it aims to answer is:

- Does a lower magnitude of intraoperative alpha wave power correlate with a longer time for patients to emerge from general anesthesia?

Participants will:

* Undergo a standardized general anesthesia (GA) protocol for elective surgery. * Have their EEG activity recorded using a standard clinical BIS™ anesthetic depth monitor during the procedure. * Have their time to awakening precisely measured after the cessation of anesthetic gases.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

35 year–50 year

Sex eligibility

All sexes

Study type

Observational

About this study

General anesthesia (GA) is an essential technique in modern medicine, used to induce unconsciousness, analgesia, and immobility in patients during surgical procedures. Since no single drug can achieve all these conditions, a combination of agents acting on the central nervous system (CNS) is employed. These include GABAergic hypnotics, such as propofol and halogenated gases; opioids, such as remifentanil and fentanyl; and neuromuscular blocking agents, such as rocuronium. The co-administration of these drugs generates multiple interactions that allow anesthesia to be induced and maintained under predictable conditions, solidifying the concept of "balanced anesthesia." However, one of the major challenges in its management is the adequate titration of drugs according to the individual needs of each patient, in order to avoid both overdosing and underdosing, both of which pose potential risks to patient safety.

In this context, electroencephalography (EEG) has emerged as a key tool for monitoring anesthetic depth, providing real-time information on cerebral activity. The analysis of electroencephalographic patterns and spectrograms, particularly alpha wave power, has proven to be a useful indicator of the degree of decreased cerebral activity during general anesthesia. Furthermore, previous studies suggest that alpha wave power may correlate with anesthesia recovery time (Gutierrez et al., Anesthesia & Analgesia, 2021) and possibly with individual sensitivity to general anesthetics. However, this relationship has not yet been fully elucidated, as a systematic study confirming this correlation has not been conducted. Establishing a correlation between emergence time and alpha band power would allow us to determine individual sensitivity to the effects of general anesthetics.

General Objective:

To determine whether patients who are more sensitive to the effects of general anesthetics have a lower relative power in the alpha band and a longer emergence time from general anesthesia.

Specific Objectives:

  • - To quantify the relative alpha power in the electroencephalogram (EEG) spectrogram using an anesthetic depth monitor during the maintenance phase of general anesthesia in the study cohort.
  • - To precisely record the anesthetic emergence time, defined as the interval from the cessation of volatile anesthetic administration to the patient's recovery of consciousness (e.g., eye opening or response to verbal command).
  • - To statistically determine the correlation and magnitude of association between the quantified relative alpha power and the measured anesthetic emergence time.

Working Hypothesis Patients exhibiting greater cerebral sensitivity to general anesthetics, as indicated by a lower magnitude of relative alpha power during the maintenance phase, will experience a statistically significant prolongation of the anesthetic emergence time.

Methodology Materials and Methods: Subjects Following approval by the Ethics Committee of the Hospital Clínico Universidad de Chile, we will conduct an observational study on a cohort of patients undergoing general anesthesia. Given that only parameters obtained from a monitor and the time it takes for a patient to recover consciousness will be observed, an exemption from obtaining informed consent was approved by the ethics committee.

Study Protocol Patients will undergo conventional general anesthesia without major interventions. A BIS™ anesthetic depth monitor, which is routinely used in clinical practice, will be utilized to record anesthetic depth. The anesthesiologist will be requested to document the drugs used and to maintain general anesthesia, as is normally performed at our hospital, with sevoflurane at a standard dose of 0.8 to 0.9 MAC. Once the surgery is finished and anesthetic emergence begins, the minute the sevoflurane supply is stopped will be recorded. The moment consciousness is recovered, determined by eye opening and response to verbal or tactile stimuli (as is typically done in all general anesthetics), will be recorded.

In detail, a traditional general anesthetic at the Hospital Clínico de la Universidad de Chile consists of:

  • Intravenous bolus administration of fentanyl at a dose of 3 mcg/kg.
  • Subsequently, intravenous lidocaine administration at a bolus dose of 1 mg/kg, followed by the administration of an intravenous bolus of propofol at a dose of 2 mg/kg.
  • Once the patient loses consciousness, the NMBA IV is administered at a dose of 0.6 mg/kg of rocuronium.
  • The patient is then orotracheally intubated and connected to a mechanical ventilator.
  • Anesthetic maintenance is achieved with sevoflurane and repeated doses of fentanyl and/or rocuronium as needed.
  • Basic and necessary monitoring at all times consists of an electrocardiogram, pulse oximetry, capnography, intermittent non-invasive blood pressure, and anesthetic depth monitoring.
  • For anesthetic emergence, the effect of neuromuscular blockers must be reversed, and sevoflurane is eliminated until the patient recovers consciousness.

As this is an observational study, the clinician responsible for the patient will administer the drugs they deem necessary and perform the relevant clinical measures; we will only record these actions.

Statistics A descriptive statistical analysis will be performed for each type of variable, expressing the results as percentages, medians, or means as appropriate. The records from the anesthetic depth monitor will be analyzed using MATLAB to determine the magnitude of the power in the alpha band. The sample size was calculated assuming that the alternative hypothesis (H1) for the linear correlation between alpha power and emergence time is r² = 0.4 ± 0.3, while the null hypothesis (H0) is r² = 0. Considering a statistical power of 90%, an alpha error of 0.05, a two-tailed analysis, and a possible loss of 20% of the data, it was determined that 70 patients are required (calculation performed with G*Power 3.1.9.4). Statistical analyses will be conducted using GraphPad Prism and R.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elective surgery under general anesthesia
  • Age 35-50 years
  • ASA physical status I-II

Exclusion criteria

  • Neurological or psychiatric disorders
  • Use of psychotropic drugs or opioids
  • Altered consciousness
  • BMI > 35 kg/m²
  • Renal, cardiac, or hepatic dysfunction
  • Emergency surgery
  • Pregnancy
  • Regional anesthesia

Treatment and study plan

Intraoperative EEG Recording

Procedure

Patients will be monitored with a frontal EEG during general anesthesia using the BIS Monitor to calculate alpha power

Primary outcomes

  1. Anesthesia emergence time

    Time frame: 60 minutes

    Minutes from the end of the sevoflurane administration until eye opening to verbal stimulus

Secondary outcomes

  1. Relative alpha power

    Time frame: 60 minutes

    Relative alpha power from the frontal EEG under general anesthesia

  2. Absolute alpha power

    Time frame: 60 minutes

    Absolute alpha power from frontal EEG under general anesthesia

  3. Extubation time

    Time frame: 60 minutes

    Time from the end of administration of sevoflurane until extubation

  4. Fentanyl requirements

    Time frame: 1 day

    Total dose of fentanyl (mcg) requirement during general anesthesia

  5. Propofol requirements

    Time frame: 1 day

    Total dose of propofol (mg) during general anesthesia

  6. Sevoflurane requirement

    Time frame: 1 day

    Total dose of sevoflurane (mL) used during general anesthesia

  7. Relative delta power

    Time frame: 1 day

    Relative delta power from frontal EEG under general anesthesia

  8. Excitation and inhibitory EEG balance

    Time frame: 1 day

    Excitation/inhibition balance from frontal EEG under general anesthesia

  9. Burst suppression time

    Time frame: 1 day

    Cumulative burst suppression time during general anesthesia

Study contacts

Contact information is provided by the study sponsor or research team.

Antonello Penna, MD, PhD

CONTACT

[email protected]

+56229788209

Sponsors and collaborators

Lead sponsor

University of Chile

Other

Collaborators

  • Center for Advanced Clinical Research (CICA ) - University of Chile

Registry information

Acronym: ALPHA-SET

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Nov 28, 2025
Registry last updated
Nov 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.